Literature DB >> 30049738

Lung function in patients with primary ciliary dyskinesia: an iPCD Cohort study.

Florian S Halbeisen1, Myrofora Goutaki1,2, Ben D Spycher1,2, Israel Amirav3,4,5, Laura Behan6,7, Mieke Boon8, Claire Hogg9, Carmen Casaulta2,10, Suzanne Crowley11, Eric G Haarman12, Bulent Karadag13, Cordula Koerner-Rettberg14, Michael R Loebinger15, Henryk Mazurek16, Lucy Morgan17, Kim G Nielsen18, Heymut Omran19, Francesca Santamaria20, Nicolaus Schwerk21, Guillaume Thouvenin22,23,24, Panayiotis Yiallouros25, Jane S Lucas6, Philipp Latzin2, Claudia E Kuehni1,2.   

Abstract

Primary ciliary dyskinesia (PCD) has been considered a relatively mild disease, especially compared to cystic fibrosis (CF), but studies on lung function in PCD patients have been few and small.This study compared lung function from spirometry of PCD patients to normal reference values and to published data from CF patients. We calculated z-scores and % predicted values for forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) using the Global Lung Function Initiative 2012 values for 991 patients from the international PCD Cohort. We then assessed associations with age, sex, country, diagnostic certainty, organ laterality, body mass index and age at diagnosis in linear regression models. Lung function in PCD patients was reduced compared to reference values in both sexes and all age groups. Children aged 6-9 years had the smallest impairment (FEV1 z-score -0.84 (-1.03 to -0.65), FVC z-score -0.31 (-0.51 to -0.11)). Compared to CF patients, FEV1 was similarly reduced in children (age 6-9 years PCD 91% (88-93%); CF 90% (88-91%)), but less impaired in young adults (age 18-21 years PCD 79% (76-82%); CF 66% (65-68%)). The results suggest that PCD affects lung function from early in life, which emphasises the importance of early standardised care for all patients.
Copyright ©ERS 2018.

Entities:  

Mesh:

Year:  2018        PMID: 30049738     DOI: 10.1183/13993003.01040-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  21 in total

1.  Comparison of Multiple Breath Washout and Spirometry in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis and Healthy Controls.

Authors:  BreAnna Kinghorn; Sharon McNamara; Alan Genatossio; Erin Sullivan; Molly Siegel; Irma Bauer; Charles Clem; Robin C Johnson; Miriam Davis; Anne Griffiths; William Wheeler; Katherine Johnson; Stephanie D Davis; Margaret W Leigh; Margaret Rosenfeld; Jessica Pittman
Journal:  Ann Am Thorac Soc       Date:  2020-09

2.  Primary Ciliary Dyskinesia (PCD): A genetic disorder of motile cilia.

Authors:  Margaret W Leigh; Amjad Horani; BreAnna Kinghorn; Michael G O'Connor; Maimoona A Zariwala; Michael R Knowles
Journal:  Transl Sci Rare Dis       Date:  2019-07-04

3.  The Short Term Influence of Chest Physiotherapy on Lung Function Parameters in Children With Cystic Fibrosis and Primary Ciliary Dyskinesia.

Authors:  Bjarne Vandervoort; Django De Beuckeleer; Elke Huenaerts; Marianne Schulte; François Vermeulen; Marijke Proesmans; Thierry Troosters; Myriam Vreys; Mieke Boon
Journal:  Front Pediatr       Date:  2022-05-23       Impact factor: 3.569

4.  Validation of pediatric health-related quality of life instruments for primary ciliary dyskinesia (QOL-PCD).

Authors:  Laura Behan; Margaret W Leigh; Sharon D Dell; Alexandra L Quittner; Claire Hogg; Jane S Lucas
Journal:  Pediatr Pulmonol       Date:  2019-09-01

5.  The Primary Ciliary Dyskinesia Computed Tomography Score in Adults with Bronchiectasis: A Derivation und Validation Study.

Authors:  Jessica Rademacher; Sabine Dettmer; Jan Fuge; Jens Vogel-Claussen; Hoen-Oh Shin; Anand Shah; Paula Inês Pedro; Rob Wilson; Tobias Welte; Frank Wacker; Michael R Loebinger; Felix C Ringshausen
Journal:  Respiration       Date:  2021-04-23       Impact factor: 3.580

6.  Proceedings of the 4th BEAT-PCD Conference and 5th PCD Training School.

Authors:  Laura E Gardner; Katie L Horton; Amelia Shoemark; Jane S Lucas; Kim G Nielsen; Helene Kobbernagel; Bruna Rubbo; Robert A Hirst; Panayiotis Kouis; Nicola Ullmann; Ana Reula; Nisreen Rumman; Hannah M Mitchison; Andreia Pinto; Charlotte Richardson; Anne Schmidt; James Thompson; René Gaupmann; Maciej Dabrowski; Pleasantine Mill; Siobhan B Carr; Dominic P Norris; Claudia E Kuehni; Myrofora Goutaki; Claire Hogg
Journal:  BMC Proc       Date:  2020-06-19

7.  Severe pulmonary disease in an adult primary ciliary dyskinesia population in Brazil.

Authors:  Mary Anne Kowal Olm; Fernando Augusto Lima Marson; Rodrigo Abensur Athanazio; Naomi Kondo Nakagawa; Mariangela Macchione; Niki Tomas Loges; Heymut Omran; Samia Zahi Rached; Carmen Sílvia Bertuzzo; Rafael Stelmach; Paulo Hilário Nascimento Saldiva; José Dirceu Ribeiro; Marcus Herbert Jones; Thais Mauad
Journal:  Sci Rep       Date:  2019-06-18       Impact factor: 4.379

8.  Pulmonary exacerbations in patients with primary ciliary dyskinesia: an expert consensus definition for use in clinical trials.

Authors:  Jane S Lucas; Florian Gahleitner; Adelina Amorim; Mieke Boon; Philippa Brown; Carolina Constant; Simon Cook; Suzanne Crowley; Damien M S Destouches; Ernst Eber; Huda Mussaffi; Eric Haarman; Amanda Harris; Cordula Koerner-Rettberg; Claudia E Kuehni; Philipp Latzin; Michael R Loebinger; Natalie Lorent; Bernard Maitre; Antonio Moreno-Galdó; Kim G Nielsen; Uğur Özçelik; Lue Katrine Drasbæk Philipsen; Petr Pohunek; Eva Polverino; Jessica Rademacher; Phil Robinson; Deborah Snijders; Panayiotis Yiallouros; Siobhán B Carr
Journal:  ERJ Open Res       Date:  2019-02-01

9.  Changing clinical characteristics of non-cystic fibrosis bronchiectasis in children.

Authors:  Ela Erdem Eralp; Yasemin Gokdemir; Emine Atag; Nilay Bas Ikizoglu; Pinar Ergenekon; Cansu Yilmaz Yegit; Arif Kut; Refika Ersu; Fazilet Karakoc; Bulent Karadag
Journal:  BMC Pulm Med       Date:  2020-06-16       Impact factor: 3.317

10.  The Relationship between Genotype and Phenotype in Primary Ciliary Dyskinesia Patients.

Authors:  Ayse Ayzit Kilinc; Memnune Nur Cebi; Zeynep Ocak; Haluk Cezmi Cokugras
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.